Resultados de la búsqueda 91-100 of 2324 for Inhibition
Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies. Rochester, Minn. The purpose of this study is to determine the safety and ...
Page 1.
... inhibitors and are refractory to or intolerant to other available therapies. A Study of Prostate Cancer Care and Survivorship Among Sub-Saharan African ...
PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and they may stop growing. Drugs used in chemotherapy ...
... inhibitor quemliclustat, and chemotherapy in the second-line (2L) or greater setting in participants with locally advanced unresectable or metastatic ...
... inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery ...
Therefore, we propose to examine urinary protein crystallization inhibitors in patient populations that have been carefully phenotyped relative to renal stone ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?